EUVIMEDEUVIMED entdecken
Crossref

Dithiolane-Based Reversible “Trojan Tag” For Intracellular Protein Delivery and Prodrug Design

Yahui He, Xiaoman Yu, Yuanhao Dai, Haoran Cai, Jianhua Lu iD, Hua Lu iD

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c02118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Yahui He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Center for Soft Matter Science and Engineering, Key Laboratory of Polymer Chemistry and Physics o…. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Drug Delivery Systems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Beijing Municipality, National Science Fund for Distinguished Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prodrug strategies for protein therapeutics can enable spatiotemporal control, minimize off-target effects and improve safety. However, a universal chemical platform that concurrently enables reversible activity switching and efficient delivery remains a challenge. Here, we introduce a dithiolane-based "Trojan tag" (DTL tag) as a simple, multifunctional tool for constructing modular protein prodrugs with traceless intracellular activation. The DTL tag promotes efficient cellular internalization of diverse proteins, independent of size and isoelectric point. When applied to the anti-PD-L1 (programmed cell death ligand 1) nanobody, the DTL tag enhanced internalization of the resulting complex, effectively trimming PD-L1 from tumor cell surfaces. Furthermore, the tag served as a reduction-triggered activity switch for enzymes like luciferase and RNase A, enabling their efficient delivery and subsequent functional reactivation. Notably, the DTL tag synergized with commercial transfection reagents to enhance cytosolic delivery of RNase A, leading to enhanced cancer cell killing. This straightforward DTL platform streamlines the creation of smart protein prodrugs, offering a new strategy for developing protein prodrugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsAntineoplastic AgentsDrug Delivery SystemsHumansRibonuclease, PancreaticCell Line, TumorDrug Design

Stichwörter der Autor:innen

dithiolaneintracellular deliveryprodrugprotein therapeuticstraceless release

Substanzen

ProdrugsRibonuclease, PancreaticAntineoplastic Agents

Autor:innen und Institutionen

  • Beijing National Laboratory for Molecular Sciences, Center for Soft Matter Science and Engineering, Key Laboratory of Polymer Chemistry and Physics of the Ministry of Education, College of Chemistry and Molecular Engine…

ORCID-Profile: Jianhua Lu, Hua Lu

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Beijing Municipality
  • National Science Fund for Distinguished Young Scholars

Zitieren

APA

He, Y., Yu, X., Dai, Y., Cai, H., Lu, J., & Lu, H. (2026). Dithiolane-Based Reversible “Trojan Tag” For Intracellular Protein Delivery and Prodrug Design. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c02118

Vancouver

He Y, Yu X, Dai Y, Cai H, Lu J, Lu H. Dithiolane-Based Reversible “Trojan Tag” For Intracellular Protein Delivery and Prodrug Design. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c02118

BibTeX
@article{He2026,
  author = {He, Yahui and Yu, Xiaoman and Dai, Yuanhao and Cai, Haoran and Lu, Jianhua and Lu, Hua},
  title = {Dithiolane-Based Reversible “Trojan Tag” For Intracellular Protein Delivery and Prodrug Design},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c02118}
}
Kostenlos starten →